We are an innovative antiviral therapeutics company engaged in developing a treatment for the human papilloma virus (HPV), the worldwide leading cause of genital warts.


 TamirBio is also exploring a single, broad spectrum antiviral treatment across a number of infections, including Cytomegalovirus (CMV), Influenza, Hepatitis C, and Ebola.

Back to top